Cadonilimab in combined with gemcitabine and cisplatin in advanced biliary tract cancer (BicureX): A phase II, single-arm clinical trial.

被引：0
|
作者：
Ma, Ji
Wang, Tao
Chen, Yidi
Yang, Yi
Qiu, Yiwen
Shen, Shu
Yi, Cheng
Wang, Wentao
机构：
[1] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16158
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial
    Shroff, Rachna T.
    Javle, Milind M.
    Xiao, Lianchun
    Kaseb, Ahmed O.
    Varadhachary, Gauri R.
    Wolff, Robert A.
    Raghav, Kanwal P. S.
    Iwasaki, Michiko
    Masci, Peter
    Ramanathan, Ramesh K.
    Ahn, Daniel H.
    Bekaii-Saab, Tanios S.
    Borad, Mitesh J.
    JAMA ONCOLOGY, 2019, 5 (06) : 824 - 830
  • [42] Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer
    Takuji Okusaka
    Hiroshi Ishii
    Akihiro Funakoshi
    Kenji Yamao
    Shinichi Ohkawa
    Soh Saito
    Hiroshi Saito
    Toshio Tsuyuguchi
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 647 - 653
  • [43] Anlotinib plus sintilimab in patients with recurrent advanced endometrial cancer: A prospective open-label, single-arm, phase II clinical trial.
    Wei, Wei
    Ban, Xiaohua
    Yang, Fan
    Huang, Yongwen
    Li, Jibin
    Qiu, Ya
    Cheng, Xiaqin
    Li, Jundong
    Zheng, Min
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [44] Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer
    Okusaka, T
    Ishii, H
    Funakoshi, A
    Yamao, K
    Ohkawa, S
    Saito, S
    Saito, H
    Tsuyuguchi, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (05) : 647 - 653
  • [45] Perioperative penpulimab plus anlotinib combined with chemotherapy for locally advanced gastric cancer: A single arm, multicenter, phase II clinical trial.
    Wang, Mian
    Zhou, Wei
    Miao, Yan
    Tan, Zhaobang
    Li, Yiding
    Hong, Liu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : TPS485 - TPS485
  • [46] Biweekly cisplatin and gemcitabine in patients with advanced biliary tract cancer
    Ahn, Daniel H.
    Reardon, Josh
    Ahn, Chul W.
    Bupathi, Manojkumar
    Mikhail, Sameh
    Wu, Christina Sing-Ying
    Bekaii-Saab, Tanios
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (08) : 1671 - 1675
  • [47] Phase Ⅰ trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer
    Akinori Watanabe
    Mitsuhiro Kida
    Shiro Miyazawa
    Tomohisa Iwai
    Kosuke Okuwaki
    Toru Kaneko
    Hiroshi Yamauchi
    Miyoko Takezawa
    Hiroshi Imaizumi
    Wasaburo Koizumi
    World Journal of Gastroenterology, 2015, (19) : 5979 - 5984
  • [48] Gemcitabine Plus Cisplatin Versus Gemcitabine Chemotherapy for Advanced Biliary Tract Cancer
    Park, Jin Myung
    Ryu, Ji Kon
    Paik, Woo Hyun
    Song, Byeong Jun
    Park, Joo Kyung
    Kim, Yong-Tae
    Yoon, Yong Bum
    GASTROENTEROLOGY, 2013, 144 (05) : S529 - S529
  • [49] Cadonilimab combined with lenvatinib for neoadjuvant therapy in early-stage renal cell carcinoma with indications for partial nephrectomy but high surgical risk: A prospective single-arm phase II clinical trial.
    Dong, Pei
    Han, Hui
    Zhou, Fangjian
    Zhang, Zhiling
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL) : 530 - 530
  • [50] Neoadjuvant atezolizumab (A) with gemcitabine and cisplatin (GC) in patients (pts) with muscle-invasive bladder cancer (MIBC): A multicenter, single-arm, phase 2 trial.
    Funt, Samuel Aaron
    Lattanzi, Michael
    Whiting, Karissa
    Al-Ahmadie, Hikmat A.
    Quinlan, Colleen
    Teo, Min Yuen
    Kamradt, Jeffrey
    Khalil, Maged F.
    Ostrovnaya, Irina
    Mccoy, Asia S.
    Hettich, Grace
    Jihad, Marwah
    Folefac, Edmund
    Huang, William C.
    Bajorin, Dean F.
    Iyer, Gopa
    Bochner, Bernard H.
    Balar, Arjun Vasant
    Mortazavi, Amir
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345